NFKB1 and cancer: In different cancers the NF-kB pathway become dysregulated (Perkins, 2007) including colon, breast, liver, ovarian, leukemia and lymphoma cancers (Bassères and Baldwin, 2006; Prasad et al., 2010; Arkan and Greten, 2011).